Tetramethylammonium Ion

Tetramethylammonium Ion

SCHEMBL216795

C[N+](C)(C)C.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Tetramethylammonium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.56
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA12 O43570 1/20 0.52
CA3 P07451 1/20 0.52
CA6 P23280 1/20 0.52
CA5A P35218 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA5B Q9Y2D0 1/20 0.52
CYP3A4 P08684 3/20 0.50
LMNA P02545 2/20 0.50
CYP2D6 P10635 2/20 0.50
TLR9 Q9NR96 1/20 0.50
MAPK1 P28482 1/20 0.50
THPO P40225 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 4/20 0.46
TDP1 Q9NUW8 3/20 0.46
CYP2C9 P11712 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30389429 0.92 GAA (0.59) GAACA1CA2CA12CA3
SCHEMBL11656541 0.91 CA1 (0.54) GAACA1CA2CA12CA3
SCHEMBL6034154 0.90 GAA (0.62) GAACA1CA2CA12CA3
SCHEMBL10663598 0.90 GAA (0.62) GAACA1CA2CA12CA3
SCHEMBL948872 0.90 GAA (0.62) GAACA1CA2CA12CA3
Silver SCHEMBL241660 0.90 GAA (0.62) GAACA1CA2CA12CA3
SCHEMBL2138368 0.90 GAA (0.62) GAACA1CA2CA12CA3
SCHEMBL22615914 0.90 GAA (0.62) GAACA1CA2CA12CA3
SCHEMBL20583857 0.90 GAA (0.62) GAACA1CA2CA12CA3
SCHEMBL6917586 0.90 GAA (0.62) GAACA1CA2CA12CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119219233-A Nitrate removal method for salt-separating mother liquor of chemical high-salt wastewater 北京恒其德生科技有限公司 2024-12-31 CN claimed
CN-118725600-A LCP film and preparation method and application thereof 江苏沃特特种材料制造有限公司 2024-10-01 CN claimed
CN-117587472-A Electroplating solution for through blind hole co-plating and application thereof and method for through blind hole co-plating of HDI board 上海天承化学有限公司 2024-02-23 CN claimed
CN-115850181-A Method for synthesizing prochloraz 江西汇和化工有限公司 2023-03-28 CN claimed
CN-115819320-A Synthesis method of spirotetramat 江西汇和化工有限公司 2023-03-21 CN claimed
EP-1695142-B1 ANTIREFLECTIVE COATINGS FOR VIA FILL AND PHOTOLITHOGRAPHY APPLICATIONS AND METHODS OF PREPARATION THEREOF HONEYWELL INT INC (US) 2019-07-31 EP claimed
CN-106029658-A Method for preparing thiamethoxam 龙灯农业化工国际有限公司 2016-10-12 CN claimed
US-6773822-B2 ANTIFUNGAL AGENT MAY BE PRESENT IN THE GYPSUM CORE AND/OR ON ONE OR BOTH OF THE PAPER FACINGS, AND MAY BE ENCAPSULATED IN A MATERIAL THAT RELEASES THE ANTIFUNGAL AGENT OVER TIME AND/OR UPON EXPOSURE TO MOISTURE. TEMPLE-INLAND FOREST PRODUCTS CORPORATION 2004-08-10 US claimed
EP-1092700-B1 Process for the preparation of unsaturated 4,5-allene ketones, 3,5-dienketones and the corresponding saturated ketones DEGUSSA (DE) 2003-10-22 EP claimed
EP-1051666-B1 SOLUTION OF TETRAMETHYL AMMONIUM HYDROXIDE IN WATER, PROCESS FOR PREPARING THE SOLUTION AND USE THEREOF INFINEON TECHNOLOGIES AG (DE) 2003-04-09 EP claimed
US-6472130-B1 Solution of tetramethylammonium hydroxide in water and a process for preparing the solution INFINEON TECHNOLOGIES AG (DE) 2002-10-29 US claimed
US-6380437-B1 REACTING A TERTIARY PROPARGYL ALCOHOL WITH ALKENYL ALKYL ETHER OR KETAL; HEATING, PRESSURIZATION IN PRESENCE OF SULFONIC ACID DEGUSSA AG (DE) 2002-04-30 US claimed
EP-1092700-A1 Process for the preparation of unsaturated 4,5-allene ketones, 3,5-dienketones and the corresponding saturated ketones Degussa-Hüls Aktiengesellschaft (DE) 2001-04-18 EP claimed
US-5356748-A Nonaqueous solvent containing dispersed resin grains and graft polymer stabilizer FUJI PHOTO FILM CO., LTD. (JP) 1994-10-18 US claimed
EP-0461320-B1 In mold coating compositions GENCORP INC (US) 1994-03-09 EP claimed
US-4575838-A Sandwich-type capacitive electronic discs RCA CORPORATION (US) 1986-03-11 US claimed
JP-57002882-A None JP disclosed
US-20260146026-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT ADEKA CORPORATION (JP) 2026-05-28 US disclosed
JP-S572882-A MANUFACTURE OF 3,4,5-TRIALKOXYBENZALDEHYDE OTSUKA CHEM CO LTD 1982-01-08 JP disclosed
US-3980594-A Trimerization of aromatic isocyanates catalyzed by certain ammonium salts THE GENERAL TIRE & RUBBER COMPANY (US) 1976-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146026-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT CBR3, CBR1, NOTUM GAA 4051/4885CA1 467/4885CA2 1035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.